Creative Planning
AVNS

Creative Planning’s Avanos Medical AVNS Stock Holding History

Creative Planning’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
85,626
+15,893
+23% +$372K ﹤0.01% 2034
2026
Q1 		$977K Buy
69,733
+4,849
+7% +$65.3K ﹤0.01% 2489
2025
Q4 		$729K Sell
64,884
-27,153
-30% -$311K ﹤0.01% 2531
2025
Q3 		$1.06M Buy
92,037
+56,756
+161% +$665K ﹤0.01% 2053
2025
Q2 		$432K Buy
35,281
+23,745
+206% +$299K ﹤0.01% 2600
2025
Q1 		$165K Buy
11,536
+9,743
+543% +$152K ﹤0.01% 3138
2024
Q4 		$28.5K Buy
+1,793
New +$35.5K ﹤0.01% 3302
2023
Q4 		– Sell
-251
Closed -$5.08K – 2773
2023
Q3 		$5.08K Buy
+251
New +$5.69K ﹤0.01% 2714
2022
Q2 		– Sell
-30
Closed -$1K – 2289
2022
Q1 		$1K Buy
+30
New +$966 ﹤0.01% 2315
2018
Q4 		– Sell
-4,252
Closed -$291K – 1959
2018
Q3 		$291K Sell
4,252
-1
-0% -$64 ﹤0.01% 1420
2018
Q2 		$243K Sell
4,253
-502
-11% -$26.5K ﹤0.01% 1501
2018
Q1 		$219K Sell
4,755
-139
-3% -$6.6K ﹤0.01% 1548
2017
Q4 		$226K Sell
4,894
-824
-14% -$37.9K ﹤0.01% 1519
2017
Q3 		$257K Sell
5,718
-183
-3% -$7.81K ﹤0.01% 1436
2017
Q2 		$232K Buy
5,901
+222
+4% +$8.39K ﹤0.01% 1432
2017
Q1 		$216K Buy
5,679
+830
+17% +$32.3K ﹤0.01% 1436
2016
Q4 		$179K Buy
4,849
+253
+6% +$9.04K ﹤0.01% 1461
2016
Q3 		$159K Sell
4,596
-80
-2% -$2.8K ﹤0.01% 1542
2016
Q2 		$152K Sell
4,676
-242
-5% -$7.41K ﹤0.01% 1408
2016
Q1 		$141K Sell
4,918
-1,167
-19% -$31.1K ﹤0.01% 1418
2015
Q4 		$203K Buy
6,085
+1,740
+40% +$54.1K ﹤0.01% 1189
2015
Q3 		$124K Buy
+4,345
New +$152K ﹤0.01% 1468
2015
Q2 		– Sell
-8,524
Closed -$419K – 1239
2015
Q1 		$419K Buy
8,524
+4,086
+92% +$189K ﹤0.01% 813
2014
Q4 		$202K Buy
+4,438
New +$174K ﹤0.01% 1131

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Creative Planning's AVNS Position: Q2 2026 in Review

Creative Planning increased its Avanos Medical (AVNS) stake by 23% in Q2 2026, buying an estimated $372K and bringing the position to 85,626 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2034.

Creative Planning first reported a position in AVNS in Q4 2014 and has held it in 24 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Creative Planning held 85,626 shares of Avanos Medical worth $2.13M as of Q2 2026.
  • Creative Planning bought 15,893 Avanos Medical shares in Q2 2026, an estimated $372K.
  • Avanos Medical made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2034 holding.
  • Creative Planning first reported a position in Avanos Medical in Q4 2014 and has held it in 24 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.